Search for: "Patent Docs" Results 721 - 740 of 1,321
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Mar 2011, 8:38 pm by Marie Louise
Highlights this week included: Humira (Adalimumab) – US: $1.67B verdict overturned by CAFC, patent invalidated over written description: Centocor v Abbott (Peter Zura’s 271 Patent Blog) (Patently-O) (Patently-O) (Patent Law Practice Center) (Patent Docs) (IPBiz) Fexofenadine – Australia: Anti-histamine inventive… but not novel, says Federal Court! [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks invalidation of five… [read post]
5 Oct 2011, 3:44 am by Marie Louise
  General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No:… [read post]
5 Oct 2011, 3:44 am by Marie Louise
  General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No:… [read post]
19 Oct 2010, 10:42 pm by Marie Louise
Honeywell (Patents Post-Grant) (IPBiz) (Patently-O) US: ‘At home’ testing for BRCA gene mutations (Patent Docs) US: New draft guidance for industry: INDs – determining whether human research studies can be conducted without an IND (FDA Law Blog) US: Patent extensions: some academic perspectives? [read post]
22 May 2009, 11:49 pm
A post on 22 May at IPWatchDog titled Patent Examiners Told To Issue Patents includes the text: The patent examiner told Mark that about 2 weeks ago management told the examining corps that they need to start issuing patents. [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June:… [read post]
26 Apr 2017, 12:26 am by Dennis Crouch
Docs: SecureAxcess_EFF SecureAxcess_ClearingHouse SecureAxcess_Petition     [read post]
19 Feb 2014, 9:59 am by Lawrence B. Ebert
Co., 520 U.S. 17, 36 (1997) (“The known interchangeability of substitutes for an element of a patent is one of the express objective factors . . . bearing upon whether the accused device is substantially the same as the patented invention. [read post]
27 Mar 2013, 1:35 pm by Florian Mueller
Here's a recap of the procedural context:Judge Pender had handed down his initial determination (the original one, prior to remand) in October 2012 and held Samsung to infringe four Apple patents, but also blessed workarounds with respect to three utility patents (the fourth patent found infringed was a design patent, and those can always be designed around). [read post]
3 Apr 2009, 4:50 am
(IPKat) US: Third follow-on biologics bill, Promoting Innovation and Access to Life-Saving Medicine Act in 111th Congress; draws industry ire (Patent Docs) (Law360) US: CAFC: Anticipation of genus by prior art species in long list: In re Gleave (Hal Wegner) (Patent Docs) US: Life Technologies, General Electric settle patent suit over DNA amplification kits (Law360)   Products Concerta (Methylphenidate) – US: Delaware court rules Watson… [read post]
27 May 2011, 5:20 am by Stefanie Levine
”  Patent Docs has an excellent explanation of the opinion and the case background. [read post]
10 Jul 2007, 9:40 am
” Links: [www.reginfo.gov] [www.reginfo.gov] ===== AGENCY: DOC-PTO RIN: 0651-AB93 TITLE: Changes to Practice for Continuing Applications, Requests for Continued Examination Practice, and Applications Containing Patentably Indistinct Claims Changes to Practice for Continuing Applications, Requests for Continued Examination Practice, and Applications Containing Patentably Indistinct Claims … [read post]
16 Mar 2011, 3:50 am by Marie Louise
Actavis (Kluwer Patent Blog) Valsartan – Norway: Valsartan case goes on appeal: Novartis v Actavis (The SPC Blog) Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement complaint against Accord following Para IV challenge (Patent Docs) [read post]
20 Aug 2013, 5:16 pm
“ Id. at *22-23.Conclusion"ORDERED the Defendant's Motions to Dismiss for lack of subject matter jurisdiction and failure to state a claim (Docs. 16, 17) and Intervenors' Motion to Dismiss (Doc. 39) are GRANTED. [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist'… [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent… [read post]
7 Jun 2017, 9:31 am by Dennis Crouch
Docs: 2017-06-06 Motion to Expedite Appeal v14   [read post]
25 Sep 2009, 11:50 am
Richard Belzer (a former economist with OMB), and Donald Zuhn of the Patent Docs blog. [read post]